ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)-Reference-Cited by-同舟云学术

ROS1-rearranged Non–small-cell Lung Cancer is Associated With a High Rate of Venous Thromboembolism: Analysis From a Phase II, Prospective, Multicenter, Two-arms Trial (METROS)

Published:2020-01 Issue:1 Volume:21 Page:15-20
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Chiari Rita,Ricciuti Biagio,Landi Lorenza,Morelli Anna M.,Delmonte Angelo,Spitaleri Gianluca,Cortinovis Diego L.,Lamberti Giuseppe^ORCID,Facchinetti Francesco,Pilotto Sara,Verusio Claudio,Chella Antonio,Bonanno Laura,Galetta Domenico,Cappuzzo Federico

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference20 articles.

1. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study;Blom;J Thromb Haemost,2006

2. Incidence of venous thromboembolism and its effect on survival among patients with common cancers;Chew;Arch Intern Med,2006

3. Prognosis of cancers associated with venous thromboembolism;Sorensen;N Engl J Med,2000

4. Impact of venous thromboembolism and anticoagulation on cancer and cancer survival;Kuderer;J Clin Oncol,2009

5. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients;Connolly;Clin Lung Cancer,2013

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROS1-rearranged non-small cell lung cancer: Understanding biology and optimizing management in the era of new approvals;Current Problems in Cancer;2024-12

2. Zielgerichtete Therapie des nichtkleinzelligen Lungenkarzinoms;Die Onkologie;2024-08-15

3. Importance of Testing for ROS1 Rearrangements in Non-Small Cell Lung Cancer in the Era of Targeted Therapy in a Latin American Country;Cancer Management and Research;2024-07

4. Novel therapeutic strategies for rare mutations in non-small cell lung cancer;Scientific Reports;2024-05-05

5. Recent nanotechnological aspects and molecular targeting strategies for lung cancer therapy;Journal of Nanoparticle Research;2024-05